KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Other Non-Current Liabilities (2016 - 2026)

Edwards Lifesciences has reported Other Non-Current Liabilities over the past 17 years, most recently at $502.7 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 34.66% year-over-year to $502.7 million; the TTM value through Dec 2025 reached $502.7 million, up 34.66%, while the annual FY2025 figure was $502.7 million, 34.66% up from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $502.7 million at Edwards Lifesciences, up from $362.6 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $502.7 million in Q4 2025 and troughed at $25.7 million in Q3 2022.
  • A 5-year average of $268.3 million and a median of $293.0 million in 2022 define the central range for Other Non-Current Liabilities.
  • On a YoY basis, Other Non-Current Liabilities climbed as much as 257.47% in 2022 and fell as far as 90.2% in 2022.
  • Year by year, Other Non-Current Liabilities stood at $267.3 million in 2021, then tumbled by 90.2% to $26.2 million in 2022, then skyrocketed by 1059.16% to $303.7 million in 2023, then rose by 22.92% to $373.3 million in 2024, then skyrocketed by 34.66% to $502.7 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for EW at $502.7 million in Q4 2025, $362.6 million in Q3 2025, and $421.6 million in Q2 2025.